IRIS
FURLAN, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.966
NA - Nord America 3.385
EU - Europa 1.930
SA - Sud America 1.299
AF - Africa 91
Totale 11.671
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.234
SG - Singapore 2.209
CN - Cina 1.347
BR - Brasile 1.131
HK - Hong Kong 774
SE - Svezia 451
IT - Italia 372
RU - Federazione Russa 337
VN - Vietnam 280
DE - Germania 212
GB - Regno Unito 130
IN - India 88
FI - Finlandia 87
CA - Canada 76
AR - Argentina 68
AT - Austria 65
MX - Messico 58
NL - Olanda 58
PL - Polonia 55
BD - Bangladesh 50
ZA - Sudafrica 42
FR - Francia 38
IE - Irlanda 38
EC - Ecuador 31
ES - Italia 31
JP - Giappone 30
TR - Turchia 29
ID - Indonesia 27
IQ - Iraq 20
UA - Ucraina 16
VE - Venezuela 16
PY - Paraguay 15
PK - Pakistan 14
CO - Colombia 12
IR - Iran 12
MA - Marocco 12
SA - Arabia Saudita 12
UY - Uruguay 12
UZ - Uzbekistan 12
LT - Lituania 11
KE - Kenya 9
KR - Corea 8
TN - Tunisia 8
AZ - Azerbaigian 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
CL - Cile 6
EG - Egitto 6
OM - Oman 6
BE - Belgio 5
DZ - Algeria 5
LB - Libano 5
DO - Repubblica Dominicana 4
NP - Nepal 4
SN - Senegal 4
BO - Bolivia 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
NI - Nicaragua 3
PE - Perù 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
GY - Guiana 2
JO - Giordania 2
MY - Malesia 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
GR - Grecia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 11.671
Salva come PNG Salva come JPEG
Città #
Singapore 974
Dallas 880
Hong Kong 768
Ashburn 479
Shanghai 346
Hefei 312
Beijing 195
Lawrence 174
Princeton 172
New York 132
São Paulo 130
Los Angeles 128
Milan 115
Ho Chi Minh City 102
Moscow 83
Nuremberg 67
Boardman 57
Hanoi 54
Munich 54
Warsaw 51
Helsinki 50
Washington 50
Santa Clara 39
Brooklyn 38
Chennai 38
Dublin 37
London 32
Montreal 32
Denver 31
Rio de Janeiro 31
Atlanta 30
Turku 29
Stockholm 28
Orem 27
Rome 27
Manchester 26
Johannesburg 25
Seattle 25
Chicago 24
Amsterdam 23
Belo Horizonte 23
Poplar 23
Vienna 23
Guangzhou 22
Tokyo 22
Houston 21
Phoenix 18
San Francisco 18
The Dalles 18
Haiphong 17
Mexico City 17
Cesano Boscone 16
Toronto 16
Curitiba 15
Boston 14
Brasília 14
Falkenstein 14
Querétaro 14
Da Nang 13
Porto Alegre 13
Ankara 12
Campinas 12
Guarulhos 12
Quito 12
Salvador 12
Charlotte 11
Dhaka 11
Frankfurt am Main 11
Naples 11
Shenzhen 11
Council Bluffs 10
Montevideo 10
Osasco 10
Tashkent 10
Xi'an 10
Betim 9
Caxias do Sul 9
Jeddah 9
Kunming 9
Assago 8
Columbus 8
Fortaleza 8
Hangzhou 8
Jaboatão dos Guararapes 8
Lappeenranta 8
Nairobi 8
Natal 8
Pune 8
Ribeirão Preto 8
Santo André 8
São José 8
Baku 7
Biên Hòa 7
Goiânia 7
Piracicaba 7
Reston 7
Trieste 7
Bexley 6
Calgary 6
Campo Grande 6
Totale 6.623
Salva come PNG Salva come JPEG
Nome #
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 158
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach 111
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 108
Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up 105
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 102
Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study 82
Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome 80
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 77
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 77
Neuroinflammation in Bipolar Depression 77
A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines 76
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: A 2-year study 76
Neurofilaments light: Possible biomarker of brain modifications in bipolar disorder 73
Classical and unconventional pathways of vesicular release in microglia 71
One-year mental health outcomes in a cohort of COVID-19 survivors 71
Absence of central nervous system pathology in severe combined immunodeficiency mice intraperitoneally injected with peripheral blood lymphocytes from multiple sclerosis patients 70
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis 69
Activation of invariant NKT cells by alpha GalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma 69
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients 69
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 66
A model of HTLV-I infection in the SCID mouse 66
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder 66
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 64
INCREASE OF MYELOID MICROVESICLES IN THE CEREBROSPINAL FLUID AS BIOMARKER OF MICROGLIA/MACROPHAGE ACTIVATION IN NEUROLOGICAL DISORDERS 63
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis 63
miR-21 sustains CD28 signalling and low-affinity T-cell responses at the expense of self-tolerance 63
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 62
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life 60
The microrna let-7b-5p is negatively associated with inflammation and disease severity in multiple sclerosis 60
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers 59
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis 59
In vivo fate analysis reveals the multipotent and self-renewal features of embryonic AspM expressing cells 59
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 59
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 59
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 59
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 58
Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs 58
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis 58
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 57
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors 57
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates 56
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects 55
Adenovirus-mediated IL-4 transfer is protective in ischemia/reperfusion brain injury 55
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 55
Dysregulation of MS risk genes and pathways at distinct stages of disease 55
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 55
Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder 55
2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis 55
Absence of immunoglobulin restriction in tears from multiple sclerosis patients 54
A single nucleotide ADA genetic variant is associated to central inflammation and clinical presentation in MS: Implications for cladribine treatment 54
Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients 54
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease 54
Indoleamine 2,3-Dioxygenase Deletion to Modulate Kynurenine Pathway and to Prevent Brain Injury after Cardiac Arrest in Mice 53
ACID SPHINGOMYELINASE TRIGGERS P2X7-INDUCED MICROPARTICLE RELEASE FROM GLIAL CELLS 53
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 53
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 53
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking 53
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 53
A helper dependent adenovirus efficiently delivers bioactive FGF-II to the CNS 52
Inflammatory Markers Predict Blood Neurofilament Light Chain Levels in Acute COVID-19 Patients 52
iAstrocytes do not restrain T cell proliferation in vitro 52
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 52
Gene and stem cell therapy for autoimmune demyelination 52
Acid sphingomyelinase activity triggers microparticle release from glial cells 51
Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss 51
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 51
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 50
Acid sphingomyelinase activity triggers microparticle release from glial cells (vol 28, pg 1043, 2009) 50
Administration of an MCP-1 variant to EAE mice prevents inflammatory cell recruitment and protects from demyelination and axonal loss 49
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis 49
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup 48
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 48
The unfolded protein response in amyotrophic later sclerosis: Results of a phase 2 trial 48
Extracellular vesicles from adipose mesenchymal stem cells target inflamed lymph nodes in experimental autoimmune encephalomyelitis 47
T regulatory cells are markers of disease activity in multiple sclerosis patients 47
PD-1/PD-L Axis in Neuroinflammation: New Insights 46
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis 46
Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitis 46
Motor-evoked potentials (MEPs) for monitoring chronic cortico-spinal damage in MOG35-55-induced experimental autoimmune encephalomyelitis (EAE) 45
The impact of storage on extracellular vesicles: A systematic study 45
Ventilation With Argon Improves Survival With Good Neurological Recovery After Prolonged Untreated Cardiac Arrest in Pigs 45
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 44
PD-L2 identifies a novel subpopulation of neutrophils displaying immunoregulatory features in Multiple Sclerosis 44
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 44
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression 44
ALTERED MRNA LEVELS OF CHEMOKINES AND CYTOKINES IN SCHIZOPHRENIA AND BIPOLAR DISORDER 43
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 43
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis 43
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 42
Distinct protein expression networks are activated in microglia cells after stimulation with ifn and il-4 42
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 42
Artificial intelligence techniques in the diagnosis of multiple sclerosis 42
Highlights from the seventh international congress of the international society of neuroimmunology 41
Extracellular Vesicles in Neuroinflammation 41
Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4 41
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 41
Involvement of calcitonin gene-related peptide and receptor component protein in experimental autoimmune encephalomyelitis. 41
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 41
Association between inflammation and brain microstructure in First Episode Psychosis investigated with DTI 40
Circulating cytotoxic immune cell composition, activation status and toxins expression associate with white matter microstructure in bipolar disorder 40
Totale 5.792
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.884
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 5 0 8 0 2 0
2021/2022162 6 4 1 57 14 18 16 5 7 15 7 12
2022/20231.070 398 175 50 6 8 85 37 49 28 24 201 9
2023/2024784 7 44 108 61 103 174 20 62 8 26 34 137
2024/20253.776 376 68 54 94 130 313 499 323 662 576 324 357
2025/20266.237 1.036 1.052 1.091 1.911 1.048 99 0 0 0 0 0 0
Totale 12.113